Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Angiogenesis Inhibitors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00322400
What this trial is testing

Phase1b to Evaluate Safety of AMG706 in Combination With Paclitaxel or Docetaxel for Breast Cancer

Who this might be right for
Locally Recurrent and Metastatic Breast Cancer
Amgen 46
Post-approval studies (Phase 4)UnknownNCT00777504
What this trial is testing

Study to the Optimal Duration of Therapy With Oral Angiogenesis Inhibitors

Who this might be right for
Renal Cell CarcinomaGastrointestinal Stromal Tumor
Radboud University Medical Center 30
Testing effectiveness (Phase 2)Ended earlyNCT01492192
What this trial is testing

RGD-PET-CT in Cancer Angiogenesis

Who this might be right for
Carcinoma, Renal Cell
Oxford University Hospitals NHS Trust 10
Testing effectiveness (Phase 2)UnknownNCT06161272
What this trial is testing

Fluzoparib With or Without Apatinib in Platinum-sensitive Relapsed Ovarian Cancer Previously Treated With PARPi

Who this might be right for
Ovarian CancerHigh Grade Serous Adenocarcinoma of OvaryPrimary Peritoneal Carcinoma+1 more
Guangxi Medical University 80
Not applicableEnded earlyNCT01507740
What this trial is testing

Profile of Soluble and Cellular Biomarkers and of Functional Imaging During Antiangiogenic Therapies in Cancer Patients

Who this might be right for
Hepatocellular CancerNon-small Cell Lung CancerRenal Cell Cancer+1 more
Medical University Innsbruck 60
Not applicableStudy completedNCT02923206
What this trial is testing

Proof-of-Concept Trial on Selective Removal of sFlt-1 in Pregnant Women With Preeclampsia Via Apheresis

Who this might be right for
Preeclampsia
Miltenyi Biomedicine GmbH 21
Early research (Phase 1)Ended earlyNCT01252095
What this trial is testing

Study of the Safety and Tolerability of PG545 in Patients With Advanced Solid Tumours

Who this might be right for
Advanced Solid Tumours
Zucero Pty Ltd 4
Not applicableStudy completedNCT01398306
What this trial is testing

Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours.

Who this might be right for
CarcinomaCarcinoma, Renal CellNeuroendocrine Tumors+2 more
University Medical Center Groningen 40
Large-scale testing (Phase 3)Study completedNCT02034006
What this trial is testing

The Criteria Establishing the Need for Re-treatment With Ranibizumab Upon Relapse in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia.

Who this might be right for
Choroidal Neovascularization Secondary to Pathologic Myopia
Novartis Pharmaceuticals 200
Large-scale testing (Phase 3)Study completedNCT00532155
What this trial is testing

Aflibercept Versus Placebo in Patients With Second-Line Docetaxel for Locally Advanced or Metastatic Non-Small-Cell Lung Cancer

Who this might be right for
CarcinomaNon Small Cell Lung
Sanofi 913
Testing effectiveness (Phase 2)Study completedNCT04518852
What this trial is testing

TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC

Who this might be right for
Hepatocellular CarcinomaLiver NeoplasmsDigestive System Neoplasms+5 more
Sichuan Cancer Hospital and Research Institute 27
Testing effectiveness (Phase 2)Study completedNCT02560779
What this trial is testing

Trial of TRC105 and Sorafenib in Patients With HCC

Who this might be right for
Hepatocellular Carcinoma
Tracon Pharmaceuticals Inc. 27
Testing effectiveness (Phase 2)Ended earlyNCT01911273
What this trial is testing

Evaluate The Efficacy And Safety of The Investigational Drug PF-03446962 (A Monoclonal Antibody With Antiangiogenic Features) In Combination With Best Supportive Care Versus Placebo Plus Best Supportive Care In Patients Affected By Recurrent Liver Cancer

Who this might be right for
Carcinoma, Hepatocellular
Pfizer 3
Testing effectiveness (Phase 2)Study completedNCT01683994
What this trial is testing

Cabozantinib Plus Docetaxel and Prednisone for Advanced Prostate Cancer

Who this might be right for
Prostatic Neoplasms
National Cancer Institute (NCI) 49
Not applicableStudy completedNCT00763672
What this trial is testing

MorbiMortality Amelioration in Preeclamptic Primiparas Study. MoMA Pre Prim Study

Who this might be right for
PregnancyPrimiparityHypertension+2 more
Assistance Publique - Hôpitaux de Paris 1,040
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06621095
What this trial is testing

Anlotinib Plus Benmelstobart and AG in First-line Treatment of Advanced Metastatic Pancreatic Cancer (ALTER-PA-001)

Who this might be right for
Pancreatic CancerFirst-lineMetastatic Pancreatic Cancer
RenJi Hospital 104
Early research (Phase 1)Study completedNCT00908869
What this trial is testing

Combination of Continuous Low Doses of Vinorelbine, Cyclophosphamide and Interferon Alpha 2b (" Metronomic Chemotherapy ") for Antiangiogenic and Antivascular Effect. Trial With Pharmacodynamic Study in Adult Advanced Neoplasm

Who this might be right for
Advanced Neoplasm
Institut Paoli-Calmettes 30
Testing effectiveness (Phase 2)UnknownNCT04052152
What this trial is testing

Anlotinib Hydrochloride Combined With Sintilimab Injection in the Treatment of Advanced Hepatocellular Carcinoma (HCC)

Who this might be right for
Advanced Hepatocellular Carcinoma
The First Affiliated Hospital with Nanjing Medical University 20
Testing effectiveness (Phase 2)WithdrawnNCT03323710
What this trial is testing

Study of Propranolol Plus Sunitinib in First-line Treatment of Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Military Institute od Medicine National Research Institute
Testing effectiveness (Phase 2)Study completedNCT00560963
What this trial is testing

Treatment of Patients Suffering From a Progressive Pancreas Carcinoma With Everolimus (RAD001) and Gemcitabine

Who this might be right for
Advanced or Metastatic Pancreatic Adenocarcinoma
Novartis Pharmaceuticals 21
Next Page